ATRX is an SWI/SNF-like chromatin remodeling protein that is mutated in several X-linked mental retardation syndromes, including the ATR-X syndrome. In mice, Atrx expression is widespread and attempts to understand its function in brain development are hampered by the lethality associated with ubiquitous or forebrain-restricted ablation of this gene. One way to circumvent this problem is to study its function in a region of the brain that is dispensable for long-term survival of the organism. The retina is a well-characterized tractable model of CNS development and in our review of 202 ATR-X syndrome patients, we found ocular defects present in 25% of the cases, suggesting that studying Atrx in this tissue will provide insight into function. We report that Atrx is expressed in the neuroprogenitor pool in embryonic retina and in all cell types of the mature retina with the exception of rod photoreceptors. Conditional inactivation of Atrx in the retina during embryogenesis ultimately results in a loss of only two types of neurons, amacrine and horizontal cells. We show that this defect does not arise from a failure to specify these cells but rather a defect in interneuron differentiation and survival post-natally. The timing of cell loss is concomitant with light-dependent changes in synaptic organization in the retina and with a change in Atrx subnuclear localization within these interneurons. Moreover, these interneuron defects are associated with functional deficits as demonstrated by reduced b-wave amplitudes upon electroretinogram analysis. These results implicate a role for Atrx in interneuron survival and differentiation.
INTRODUCTION
The X-linked alpha thalassemia mental retardation (ATR-X, MIM# 300032) syndrome is characterized by severe mental retardation, alpha thalassemia and skeletal abnormalities, as well as microcephaly and varying degrees of urogenital abnormalities (1) (2) (3) . Mutations within the ATRX gene have been identified as the underlying cause of the ATR-X syndrome and several other ADD domain (a typical plant homeodomain zinc finger motif common to ATRX, DNMT3a and DNMT3b) while the larger isoform also contains an SNF2 ATPase/helicase domain suggesting a chromatin remodeling function for both proteins. Most disease causing mutations are missense mutations that reside in these two conserved domains (10) .
Biochemical and cell biological studies have shown that ATRX localizes at pericentromeric heterochromatin and within promyelocytic leukemia-nuclear bodies (PML-NBs) where it interacts with heterochromatin protein 1 (HP1) and the transcriptional repressor Daxx (11) (12) (13) (14) . While our understanding of these interactions remains unclear, it has been shown that patient mutations attenuate the in vitro nucleosome remodeling activity of ATRX as well as alter subnuclear localization to PML-NBs, suggesting that the mutations are functional hypomorphs (13, 15, 16) . In addition, ATRX may have a role in regulating methylation, as fibroblasts isolated from ATR-X patients have an altered methylation status at specific repetitive DNA elements including the ribosomal DNA arrays (17) .
Apart from the knowledge that ATRX mutations are functional hypomorphs, very little is known about how these mutations cause mental retardation. Indeed, early lethality (embryonic day 9.5, E9.5) in Atrx complete knockout mice precludes the analysis of its function in brain development (18) . Conditional ablation of Atrx in the forebrain is associated with a reduction in the size of the cortex secondary to enhanced cell death during corticogenesis (19) . These studies suggested that defects in cell survival could contribute to the microcephaly in patients, yet the early lethality in this brain-restricted Atrx ablation model prohibits further functional studies. To overcome the limitations in these models, we have used the retina to investigate the role of Atrx in CNS development. The neuroretina, which is located at the back of the eye, is responsible for the reception and transmission of light-induced neuronal activity to the visual processing centers in the brain (Fig. 1A) . The structure of the retina is well characterized and since many of the general principles that regulate CNS development are conserved in the retina it has been a useful model for understanding the underlying cause of other MR disorders including Norrie disease, Fragile-X syndrome and Williams-Beuren syndrome (20) (21) (22) (23) (24) . Moreover, studies in Drosophila have shown that ATRX expression is predominant in the optic lobe region of third instar larvae. Overexpression of ATRX results in extensive loss of ommatidia in the Drosophila eye through apoptosis, which leads to the suggestion that ATRX may have specific functions within this tissue (25, 26) . In this study, we have reviewed the clinical findings from 202 ATR-X patients and found that a significant proportion of patients present with ocular defects, which further supports the validity of the retina as a model for understanding ATRX function. We generated conditional Atrx knockout animals using the Cre-loxP recombination system in which Atrx ablation is restricted to the peripheral retina (19, 27) . Our results show that inactivation of Atrx does not impair neuronal subtype specification, but is required for amacrine and horizontal interneuron survival during the postnatal period at the time of light-dependent changes in synaptic organization. Moreover, altered electroretinogram (ERG) measurements in these mice demonstrate that Atrx is required for normal retinal function. Taken together, these findings identify a novel role for Atrx in the regulation of interneuron survival and differentiation.
RESULTS

Opthalmic abnormalities in ATR-X patients
Previous studies investigating Atrx function in the developing brain demonstrated an important role of Atrx during corticogenesis but the early post-natal death of these mice precluded a comprehensive analysis of the types of neurons affected (19) . To assess the effect of Atrx loss on specific neuronal subtypes, we decided to use the developing mouse retina as our model of CNS development. While the ubiquitous expression of ATRX suggested that this would be a reasonable model, the relevance of the visual system as a model would be strengthened if there was evidence of visual system anomalies in ATR-X patients. Therefore, we surveyed the clinical findings of 202 ATR-X patients for indications of ophthalmic abnormalities. We observed that in 23% of patients (47/202) visual anomalies were annotated. Of the 47 cases with ophthalmic abnormalities, ATRX gene mutations were identified in 44 patients while the other 3 patients had their diagnosis confirmed by the presence of HbH inclusions in peripheral blood samples. Mutations were identified in the ADD domain (18 patients; 41%), the SNF2 domain (14 patients; 32%) and in other regions of the gene (12 patients; 27%). Moreover, the breakdown of mutations in patients with ocular defects compares with the frequency of these mutations in all patients (49% ADD domain; 30% SNF2 domain; 21% other) (1) suggesting that eye abnormalities are not associated with distinct mutations. As summarized in Table 1 , mutations in each domain are associated with each clinical feature while the most common abnormalities observed were strabismus/ squint, myopia and pale disc/optic nerve atrophy/hypoplasia. Some of these defects (optic nerve atrophy and pale disc) implicate the involvement of neural components of the eye. However, other defects such as strabismus are complex and indicate the involvement of the extra-ocular muscles and possibly, other brain regions (e.g. cerebellum). Because Atrx expression is ubiquitous, it is not unexpected that abnormalities in the visual system of these patients indicate involvement of multiple tissue types (15) .
In most instances where a visual defect was noted there was no follow-up to the original annotation. We obtained one informative ERG recording on a patient diagnosed with left exotropia and optic nerve head pallor. This analysis revealed that the amplitudes were preserved bilaterally, but there was a delay in peak latency suggesting that, at least in this patient, retinal function was impaired. However, despite the high frequency of ophthalmic abnormalities described in this patient population the extent of retinal involvement is typically not investigated extensively, which likely reflects the small impact of visual system anomalies relative to the management of the overall syndrome. The data also suggests that visual defects may be significantly under-reported in ATR-X patients. Regardless, the clinical data demonstrates that ocular abnormalities are a frequent feature of the disease.
Temporal and spatial expression of ATRX in the developing and adult retina During retinogenesis, six types of neurons and one type of glial cell are generated from a pool of multipotential progenitor Human Molecular Genetics, 2009, Vol. 18, No. 5 967 cells to form the mature retina which is organized into three discrete laminae: the outer nuclear layer (ONL), which contains rod and cone photoreceptors; the inner nuclear layer (INL), which consists of horizontal, bipolar, amacrine and Müller cells; and the ganglion cell layer (GCL), which contains both ganglion and amacrine cells (Fig. 1B) . To identify the ATRX-expressing cells in the developing mouse retina, we stained embryonic and perinatal cryosections with a polyclonal ATRX antibody that recognizes the full-length protein.
At E13.5, the retina is a simple neuroepithelium that contains dividing progenitor cells. As illustrated in Figure 1C -F, at this stage, Atrx was found to be abundantly expressed in progenitor cells throughout the retina as shown by co-localization of Atrx with the cell cycle marker Ki67. At post-natal day 0 (P0), three discrete zones along the apical-basal axis of the retinal neuroepithelium can be distinguished on the basis of cell cycle marker expression, lamination and cell morphology: an outer neuroblast layer that contains dividing progenitor cells, and an inner neuroblast layer and GCL where postmitotic neurons reside. At this developmental stage two discrete populations of Atrx positive cells could be distinguished. As shown in Figure 1G -J Atrx is expressed at low levels in progenitor cells, as indicated by co-localization with Ki67 in the outer region of the neuroblast layer, while a higher Atrx (Fig. 1L ). In the mature retina, rods greatly outnumber cone photoreceptors, the latter accounting for only 3% of the cellular makeup of the ONL. To confirm that these Atrx immunopositive cells in the ONL were indeed cone photoreceptors, we immunostained retinal sections from Nrl 2/2 mice, in which all of the photoreceptors differentiate as cones (28) . Cells in the ONL of NRL 2/2 retinas exhibit perinuclear Atrx staining, thus confirming the expression of Atrx in cone photoreceptors (Fig. 1M,N) . Based on our immunolocalization study, we can conclude that Atrx is expressed in progenitor cells throughout retinal development and persists in all differentiated cell types with the exception of rod photoreceptors. Moreover, beginning at E15.5 increased Atrx staining is detected in post-mitotic cells compared with progenitor cells.
Conditional deletion of Atrx results in interneuron abnormalities
To study the biological function of Atrx during retinal development the use of a conditional system is required as complete Atrx inactivation results in early embryonic lethality (18) . Therefore, we used a Cre-recombination system to target Atrx inactivation to the retina. Atrx floxed mice were bred to mice expressing Cre under the control of a regulatory element of the murine Pax6 promoter (a-Cre) (19, 27) . This crossgenerated a-Cre;Atrx f/y animals which exhibited a loss of Atrx beginning at E10 in the peripheral retina. For simplicity, these animals will be referred to subsequently as Atrx KO throughout the text. a-Cre mice express GFP and Cre from a bicistronic mRNA which allowed us to use GFP as a surrogate marker to simultaneously monitor Cre expression and inactivation of the full-length Atrx protein via IHC. At all time points observed, including E13.5 and adult ( Fig To characterize the impact of Atrx ablation on retinal development, we performed immunohistochemical studies on the retinas of adult (6 -8 weeks) Atrx KO mice. Upon initial observation, the gross morphology and organization of Atrx KO retinas did not differ from their wild-type counterparts ( Fig. 2E-F ). Immunohistochemical analysis with a panel of cell-type-specific markers revealed no obvious deficiencies in the morphology and number of RGCs (Brn3bþ), rod (rhodopsinþ) and cone (cone-arrestinþ) photoreceptors, rod bipolar cells (PKCa) and Müller glia (CRALBPþ) (Supplementary Material, Fig. S3A -J) . However, we did observe striking differences in the expression of the horizontal cell marker calbindin (arrows in Fig. 2G-H) , the pan-amacrine marker syntaxin and the width of the IPL, where amacrine, bipolar and RGC processes are located (Fig. 2I versus J) . Cell counting confirmed a 37% reduction in horizontal cells (calbindinþ) and a 34% reduction in amacrine cells in the INL (Pax6þ) in the peripheral retina of Atrx KO mice (Fig. 2K) . To determine if the decrease in Pax6 and syntaxin immunoreactivity in Atrx KO retinas was due to the aberrant (Fig. 2K) . Quantification of the other INL cell types Müller (CRALBPþ) and bipolar cell (Chx10þ) as well as cone photoreceptors (Cone-arrestinþ) also revealed that these cell types were present in equal number in both wild-type and Atrx KO retinas (Fig. 2K) . Taken together these results suggest that Atrx may play a potential role in the development or survival of amacrine and horizontal cells.
To examine whether the amacrine cell phenotype observed in Atrx KO retinas was due to the selective loss of a specific amacrine subtype or a uniform loss of the amacrine cell class, we again performed an immunohistochemical analysis of adult retinas using subtype specific markers. Morphological studies of the mammalian retina have identified close to 30 distinct subtypes of amacrine cells, all of which are present in defined ratios and with discrete roles in the processing of information through the INL (29) . As a result of their extreme heterogeneity, to date only a handful of molecular markers for distinct amacrine subtypes have been identified. 970
A list of some of these markers is appended in Supplementary Material, Table S1 . Immunohistochemical analysis revealed a reduction in all amacrine subtype specific markers tested in Atrx KO mice. As illustrated in Figure 3A -L, Glycine Transporter 1 (Glyt1), Calretinin, Choline Acetyltransferase (ChAT), Prox1 and Tyrosine hydroxylase (TH) staining was reduced in the retinas of Atrx KO animals. Cell scoring confirmed a significant reduction in the number of Glyt1þ, Calretininþ and Prox1þ amacrine cells in the Atrx KO retina compared with the control animals (Fig. 3N) . Because of their low number it was difficult to accurately quantify differences in the number of ChATþ and THþ amacrine cells in sections of Atrx KO animals, however, staining for these markers in neuronal processes was reduced and abnormal.
As TH staining in cell processes was less intense in the Atrx KO retina, we examined the organization of these processes using retinal flat mount staining. One of the peculiar characteristics of adult dopaminergic innervation, which can be observed in whole mounts, is its organization into pericellular baskets surrounding the somata of glycernergic and AII amacrine neurons (30) . As illustrated in Figure 3M and O, these pericellular varicosities were significantly reduced in Atrx KO mice thereby, illustrating the disturbance of the dopaminergic network.
To confirm that the interneuron phenotype in the peripheral retina of Atrx KO mice correlated with Atrx inactivation, we analyzed interneuron marker expression in the central retina where Atrx expression is abundant. Similar Calretinin, Prox1 and TH staining was observed in the central retinas of both Atrx KO and wild-type mice (Supplementary Material, Fig. S4 ). Thus, our data demonstrates that Atrx inactivation results in a significant reduction in horizontal cells and in multiple subtypes of amacrine neurons.
Loss of Atrx has no impact on the embryonic development of amacrine cells
Atrx is a chromatin remodeling protein thought to regulate the transcription of specific target genes. Thus, we reasoned that it might regulate genes necessary for the proper development of amacrine and horizontal cells. Therefore, we examined the expression pattern of basic-helix-loop helix (bHLH) and homeodomain transcription factors necessary for the generation of these cell types. Horizontal cell development begins around E12 and ends a few days before birth, while amacrine cell development spans a 2-week period, starting at E11 and ending around P3 (31) . As such, we selected E17.5 as a time point encompassing both horizontal and amacrine cell development to perform quantitative RT-PCR (Q-RT-PCR) analysis for gene expression on wild-type and Atrx KO retinas. While we observed a greater than 2-fold decrease in Atrx expression in Atrx KO retinas, no change in the expression of previously identified regulators of amacrine and horizontal cell fate, namely Foxn 4, NeuroD1, NeuroD4, Pax6, Prox1, Ptf1a and Lim1 was observed. (Supplementary Material, Fig. S5A ).
Although we were unable to quantify changes in the embryonic gene expression profile of Atrx KO retinas, it remained a possibility that interneuron deficiency in Atrx KO animals reflected a failure to generate these cells.
Therefore, we performed BrdU birthdating experiments at three embryonic stages (E13.5, E15.5 and E17.5) to address whether the reduction in amacrine cell number resulted from impaired embryonic development. Pups were harvested at birth and their retinas were stained for BrdU. There was no significant difference in the number of intensely labeled cells located in the inner half of the INBL (amacrine cells) or the GCL (displaced amacrine cells and RGC) in wild-type and Atrx KO retinas (Supplementary Material, Fig. S5B,C) . Thus, Atrx is not required during embryonic development for the generation of amacrine cells and RGCs, but may have an important role at later stages for their differentiation.
Amacrine and horizontal cell survival is compromised in Atrx KO retinas
Given that the generation of amacrine cells at three embryonic stages was unaltered in Atrx KO mice we were prompted to examine the status of amacrine cells at different stages in the post-natal retina. The number of Pax6 positive amacrine cells was not significantly different at P7 and P10 in both wildtype and mutant retinas (Fig. 4A) . By P14, the number of amacrine cells was reduced, albeit not significantly. However, by P17 there was a significant reduction in amacrine cell number in the Atrx KO retina compared with wild-type (Fig. 4A) . The number of amacrine cells in the Atrx KO retina remained stable after P17, demonstrating that amacrine cell loss is not progressive. Although amacrine cell loss did not correlate with an increase in TUNEL staining, this is likely because of the gradual loss of these cells over a 7-day period (Supplementary Material, Fig. S6A) .
Interestingly, the loss of amacrine cells coincides with a change in Atrx subnuclear localization. At P7, Atrx staining in the inner half of the INL and GCL is speckled and co-localizes with regions of intense DAPI staining in the nucleus, consistent with the heterochromatin co-localization of Atrx previously reported in murine cells (12) . This nuclear speckled staining pattern gradually changes to a homogenous nuclear staining pattern by P17 (Fig. 4B ). This change in Atrx nuclear localization does not reflect a change in the status of pericentromeric heterochromatin as intense DAPI staining persists in all cells of the INL in the murine retina well into adulthood. Moreover, changes in Atrx localization were not attributed to altered protein levels as western blot analysis revealed that Atrx expression in the retina was identical at P7 and at P17 (data not shown).
Horizontal cells are also decreased by 37% in Atrx KO animals. For this cell type, we observed a decreased number of calbindinþ horizontal cells by P7 in our mutant retinas while Lim1, another marker of terminally differentiated horizontal cells, was present at similar frequency in both wild-type and Atrx KO retinas at P5 (Fig. 4C) . Cell scoring of calbindinþ horizontal cells revealed no further decline in horizontal cell number after P7, as a similar reduction in calbindin expression was found in both P7 and adult Atrx KO retinas compared with the control. Similar to our findings in amacrine cells, subnuclear localization of Atrx is altered in horizontal cells between P7 and P14 consistent with the timing of loss of this cell type. Thus, our results illustrate that disruption of Atrx expression in the retina results in the gradual loss of amacrine cells in the post-natal Fig. S6B ). Latency times, the timing between the peak of the a and b waves, were also unaffected in Atrx KO mice (Supplementary Material, Fig. S6C ). However, there was a 30% reduction in b-wave amplitude in Atrx KO animals at the five highest light intensities tested (Fig. 5B) . The oscillatory potentials (OPs) are the ERG component that has been attributed to amacrine cells. Although OPs were clearly present in Atrx KO mice, they were similarly reduced in amplitude at multiple light intensities ( Fig. 5C and data not shown) . Thus, the reduction in OPs is consistent with the reduction in amacrine cell number and the ERG analysis also highlights a requirement for Atrx to the inner retinal response to light.
DISCUSSION
Impaired sensory organ function, such as vision, is often overlooked or primarily attributed to impaired cortical function in patients with severe mental retardation (20,32 -36) . Here we present the first report describing visual system anomalies in ATR-X patients. Examination of the clinical information from 202 patients demonstrated that 23% of ATR-X patients presented with an ocular phenotype, although this number is probably still underestimated, as reports on vision were not routinely included in the clinical notes that we examined. To gain a better understanding of these clinical findings and further elucidate the function of ATRX in neuronal development, we generated transgenic mice in which ablation of the Atrx gene was restricted to the peripheral retina. Analysis of these mice revealed a post-natal depletion of interneurons and defects in retinal function as documented by electroretinography, thereby implicating Atrx in neuron survival and differentiation. We observed that Atrx was present in retinal progenitors and the expression level increased upon neuronal differentiation. Human
Expression was evident in all neuronal subtypes except rod photoreceptors and persisted in the adult. The expression pattern in the retina is similar to that observed in the developing forebrain where the progenitor cells have lower levels of Atrx than the post-mitotic neurons (19) . Despite these similarities, Atrx inactivation in the forebrain results in embryonic cell loss (19) , whereas Atrx inactivation in the retina results in cell loss during the post-natal period. This pattern of early cell loss in forebrain Atrx KO mice has been suggested to arise from delayed cell-cycle progression due to a role for Atrx in regulating chromosome dynamics during mitosis (37) . The phenotype of Atrx KO in the retina (this study) is not consistent with a global proliferation and/or survival defect since only horizontal and amacrine interneurons were affected. Similarly, the Atrx KO animals exhibit no apparent defects in their neuroprogenitor pool, as the expression of bHLH and HD transcription factors required for amacrine and horizontal specification were not changed and amacrine cells are born in appropriate numbers. Taken together, these data show that Atrx is not required for cell fate determination in the retina, but may be more important for differentiated cell function. The difference in neuronal survival in the forebrain and retinal Atrx KO models may reflect region-specific differences in Atrx target genes. Nonetheless, these findings in the retina Atrx KO highlight a post-natal requirement for Atrx in interneuron terminal differentiation that could not be appreciated in the forebrain Atrx KO model because of early lethality. Consistent with this idea, RNAi inactivation of ATRX in Drosophila leads to axonal outgrowth defects and lateral positioning of longitudinal axons in embryonic CNS neurons (25) . Interestingly, the post-natal interneuron death in the Atrx KO retina coincides with the timing of alterations in Atrx subnuclear organization and with the period of light-dependent synaptic remodeling (31, 38) , which raises the possibility that Atrx-mediated chromatin reorganization plays a role in activity-dependent neuronal maturation and/or function. Consistent with this idea, we observed gross morphological abnormalities in neuronal processes within the inner plexiform layer and altered ERG recordings suggestive of functional deficits. In this regard, the ERG recordings confirmed that the Atrx KO mice have no deficit in photoreceptor cell number and function as reflected by a normal a-wave amplitude. Similarly, a reduction in OPs confirmed the reduction in amacrine cell number that we observed. The reduced b-wave is more difficult to understand, as this portion of the ERG is thought to reflect the activity of bipolar cells and Müller glia, which in the Atrx KO retina, are present in normal numbers with no gross morphological differences. Nonetheless, altered bipolar function remains a possibility for the reduced b-wave in the Atrx KO mice, which is consistent with studies in other mutants. For example, inactivation of Vsx1, a homeobox gene, impairs the terminal differentiation and function of bipolar cells without affecting their specification and gross morphology (39) . Reduced b-waves have also been reported in mice deficient in connexin 45, which was attributed to altered neurotransmitter coupling between AII amacrine cells and bipolar cells (40) . As such, the remaining amacrine cells in the Atrx KO retina may have altered function preventing the proper propagation of signals from the bipolar cells. Regardless, altered INL function in the Atrx KO animals supports the notion that loss of amacrine and horizontal cells contribute to the altered retinal circuitry. Future studies should be aimed at identifying specific gene targets of Atrx that are important for interneuron survival and differentiation during the post-natal period.
In summary, this is the first report that links the ATR-X syndrome with a visual system anomaly. Perturbation of Atrx expression in our in vivo model highlighted a role for Atrx in the long-term survival and differentiation of interneurons, which was not previously appreciated using the forebrain-inactivation model where enhanced cell death was the prominent finding. This finding raises the possibility that approaches to restore neuronal function could be an avenue for therapeutic intervention. Indeed, recent studies on fragile X syndrome have shown that over active signaling of the metabotropic glutamate receptor mGluR5, contributes significantly to the phenotype and that it is corrected by drug treatment (41, 42) .
MATERIALS AND METHODS
Generation of transgenic animals
The a-Cre transgenic mice were obtained from P. Gruss and maintained on an FVBN background (27) . Atrx f/f mice were maintained on C57Bl/6 background (19) . To generate a-cre; Hybridoma Bank), anti-syntaxin (1/1000, Sigma), anti-GFP (1/500, Molecular Probes) and anti-glutamine synthetase (1/500, BD Bioscience). The rabbit polyclonal anti-ChAT (1/500, Chemicon International) was incubated for 24 h at room temperature. Antigen retrieval consisting of a 10 min microwave treatment in a 1Â sodium citrate solution followed by two 10 min PBS washes was required for certain antibodies. In addition to antigen retrieval, visualization of BrdU required a 15 min treatment in 2 N HCL at 378C followed by a 10 min permeabilization step in 0.1M Tris pH 8.8, 0.01% Tween 20. Antibodies were visualized with the following secondary antibodies:
Alexa Red-conjugated donkey anti-rabbit-IgG (1/1000, Molecular Probes), Alexa Red-conjugated donkey anti-mouse-IgG (1/ 1000, Molecular Probes) and Alexa Green-conjugated donkey anti-mouse-IgG (1/1000, Molecular Probes). The TUNEL assay was performed using the in situ Cell Death Detection Kit (Roche Diagnostics) according to the manufacturer's instructions. Cell nuclei were counterstained with DAPI for 5 min (10 mg/mL). Sections were mounted with DAKO fluorescence protector. Sections were analyzed on a Zeiss Axioplan microscope and digital images were captured using an AxioVision 4.6 (Zeiss) camera and processed with Adobe w Photoshop (Adobe).
Q-RT-PCR analysis
Total RNA was isolated from two different retinas harvested from the same animal using Trizol reagent (Invitrogen) followed by RNase free DNAse I (Sigma) to remove DNA contamination. Using 1 -2 mg of total RNA, first strand cDNA was synthesized using random primers and a reverse transcription cocktail containing 5Â first strand buffer, 100 mM DTT, 25 mM dNTPs and Superscript II RT (Invitrogen). Q-RT-PCR was performed using a Stratagene MÂ3000 machine with Absolute SYBR Green Q-PCR Master Mix (Abgene) under the following conditions: 10 min at 958C followed by 40 cycles of 30 s at 958C, 30 s at 598C and 30 s at 728C. Sequence-specific primers used for Q-RT-PCR for Foxn4, Lim1, Ptf1a, NeuroD1, NeuroD4 were identical to the ones previously described (45) . In addition, the following primers were used: 18S ( . Using the standard curve corresponding threshold method of quantification, PCR product formation was monitored in realtime (MÂ4000 multiplex Q-PCR system; Stratagene) and the threshold cycles were determined using the MÂ4000 software. All data were normalized to GAPDH and 18S expression levels. Threshold cycle variance in seven biological replicates was tested for significance using a two-sample Student's t-test with equal variance.
Electroretinography
ERGs were generated using the ESPION system (Diagnosys LLC, Littleton, MA) as previously described (46) . Briefly, mice that had been dark-adapted overnight were anaesthetized under safe light conditions using an intraperitoneal injection of avertin at 250 mg/kg. Eyes were dilated using both 1% tropicamide and 2.5% phenylephrine hydrochloride (Alcon Canada). To ensure constant body temperature during testing, mice were put on a warming source. Silver wire loop electrodes were placed on both corneas with a drop of 0.3% hypromellose (Novartis) to maintain corneal hydration. A gold minidisc reference electrode was placed on the tongue and a ground needle electrode was placed subcutaneously in the tail. The animal's head was positioned under the center of the Ganzfeld dome. Single flash stimuli (4 ms duration) were presented at 11 increasing intensities ranging from 0.001 to 25 cd s/m 2 . Five ERG traces were obtained and averaged for each luminance step. The minimum negativity occurring between 10 and 40 ms post-stimulus was defined as the a-wave. The maximum positivity occurring between 40 and 80 ms poststimulus was defined as the b-wave. Differences during ERG analyses were determined using ANOVA statistical analysis.
